MobiHealth News December 23, 2025
A handful of transformative transactions lifted 2025 merger and acquisitions totals, but dealmakers largely remained disciplined, prioritizing data-driven growth and digital platforms.
The total transaction value of medical technology (medtech) dealmaking in 2025 surged to $92.8 billion – the highest level in more than a decade – but overall activity remained muted, with just 46 deals announced through Nov. 30, according to PwC’s “US Deals 2026 outlook” report.
The report found the value spike was driven almost entirely by three mega-deals that dominated the year’s mergers and acquisitions (M&A) landscape.
Abbott Laboratories’ $23.5 billion acquisition of Exact Sciences led the pack, signaling continued appetite for molecular diagnostics and data-driven testing. Blackstone followed with a $20.5 billion take-private of Hologic.
Rounding...
Today's Sponsors
Today's Sponsor